Diah Kurnia Mirawati
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Diah Kurnia Mirawati has a total of 91 co-authors. Here are the top co-authors by number of shared publications:
- Stefanus Erdana Putra
Universitas Kristen Duta Wacana
16 shared publications - Muhammad Hafizhan
Department of Neurology, Sebelas Maret Teaching Hospital, Sebelas Maret University, Sukoharjo, Central Java, Indonesia
13 shared publications - Pepi Budianto
Department of Neurology, Sebelas Maret Teaching Hospital, Sebelas Maret University, Sukoharjo, Central Java, Indonesia
11 shared publications - Hanindia Riani Prabaningtyas
Universitas Sebelas Maret
10 shared publications - Rivan Danuaji
Department of Neurology, Faculty of Medicine, Universitas Sebelas Maret, Surakarta, Indonesia
10 shared publications - Ira Ristinawati
Universitas Sebelas Maret
8 shared publications
Latest Publications
- Open Access
- 12 August 2026
- Published by Faculty of Medicine, Universitas Indonesia in Medical Journal of Indonesia
- Vol. 35 (3) , 252-8
Comparing therapeutic effects of Qur’anic recitation and classical music in vascular cognitive impairment: a case series
The increasing prevalence of vascular cognitive impairment (VCI) underscores the critical need for innovative non-pharmacological strategies. This retrospective comparative case series evaluated the effects of classical music therapy, Qur’anic recitation, and their combination on cognitive function and religious engagement in 7 patients with VCI due to rare disorders, including vasculitis related to systemic lupus erythematosus and Balint syndrome. Assessments included brain magnetic resonance imaging, the Indonesian version of the Montreal Cognitive Assessment, the dementia solat score, and C-reactive protein levels. Patients who received only Qur’anic recitation demonstrated the most significant improvement in cognitive function and religious engagement. The findings suggest that Qur’anic recitation therapy has yielded superior results despite potential sound wave conflicts. Future studies with larger samples are required to validate these findings and explore further non-pharmacological interventions for VCI.
- 12 August 2026
- Published by Faculty of Medicine, Universitas Indonesia in Medical Journal of Indonesia
- Vol. 35 (3) , 252-8
Open AccessComparing therapeutic effects of Qur’anic recitation and classical music in vascular cognitive impairment: a case series
The increasing prevalence of vascular cognitive impairment (VCI) underscores the critical need for innovative non-pharmacological strategies. This retrospective comparative case series evaluated the effects of classical music therapy, Qur’anic recitation, and their combination on cognitive function and religious engagement in 7 patients with VCI due to rare disorders, including vasculitis related to systemic lupus erythematosus and Balint syndrome. Assessments included brain magnetic resonance imaging, the Indonesian version of the Montreal Cognitive Assessment, the dementia solat score, and C-reactive protein levels. Patients who received only Qur’anic recitation demonstrated the most significant improvement in cognitive function and religious engagement. The findings suggest that Qur’anic recitation therapy has yielded superior results despite potential sound wave conflicts. Future studies with larger samples are required to validate these findings and explore further non-pharmacological interventions for VCI.
- Open Access
Factors associated with quality of life in patients with epilepsy: a preliminary path analysis of psychological and neurobiological determinants
Background: Epilepsy significantly impacts various aspects of a patient’s life, extending beyond seizure control to encompass their overall well-being and quality of life. Understanding the complex interplay of direct factors, such as seizure frequency and medication side effects, alongside indirect factors like psychological distress and social support, is crucial for developing comprehensive interventions aimed at improving the lives of individuals living with epilepsy. This study aimed to determine the direct and indirect effects of anxiety, depression, and seizure frequency on the quality of life of patients with epilepsy using path analysis. Methods: This was an observational analytic study with a cross-sectional design. A total of 32 patients with primary epilepsy were recruited from the Neurology Clinic at Universitas Sebelas Maret Hospital. The mean age of the participants was 35.43 ± 14.00 years. Quality of life was assessed using the Indonesian Quality of Life in Epilepsy Inventory-10 (QOLIE-10). Anxiety and depression were measured with the Generalized Anxiety Disorder 7-item (GAD-7) and the Hamilton Depression Rating Scale (HDRS), respectively. Blood samples were used to measure cortisol and brain-derived neurotrophic factor (BDNF) levels. Path analysis was conducted in Stata 13.0 for Windows to model the hypothesized direct and indirect relationships among variables. Model fit was evaluated using Akaike Information Criterion (AIC), Bayesian Information Criterion (BIC), and absolute fit indices. Results: Path analysis revealed a significant negative direct association between BDNF levels and QOLIE-10 scores (B = −0.072, p = 0.017), indicating that higher BDNF levels are associated with improved quality of life, as reflected in lower distress scores. Conversely, seizure frequency (B = 0.23, p = 0.039) and GAD-7 scores (B = 0.70, p < 0.001) were positively associated with QOLIE-10, indicating that increased seizures and anxiety are linked to poorer quality of life. Indirect effects were also identified, with seizure frequency positively influencing both GAD-7 (B = 0.56, p < 0.001) and HDRS scores (B = 0.39, p = 0.002), which, in turn, are significant contributors to a reduced quality of life. The model demonstrated a good fit, with an AIC of 1,272.185 and a BIC of 1,315.064. Conclusions: Managing seizures is not only critical for reducing the direct burden of epilepsy but also essential for mitigating anxiety and depression, which are significant contributors to a reduced quality of life. Our findings underscore the importance of a holistic care approach that addresses seizure control and psychological well-being.
Open AccessFactors associated with quality of life in patients with epilepsy: a preliminary path analysis of psychological and neurobiological determinants
Background: Epilepsy significantly impacts various aspects of a patient’s life, extending beyond seizure control to encompass their overall well-being and quality of life. Understanding the complex interplay of direct factors, such as seizure frequency and medication side effects, alongside indirect factors like psychological distress and social support, is crucial for developing comprehensive interventions aimed at improving the lives of individuals living with epilepsy. This study aimed to determine the direct and indirect effects of anxiety, depression, and seizure frequency on the quality of life of patients with epilepsy using path analysis. Methods: This was an observational analytic study with a cross-sectional design. A total of 32 patients with primary epilepsy were recruited from the Neurology Clinic at Universitas Sebelas Maret Hospital. The mean age of the participants was 35.43 ± 14.00 years. Quality of life was assessed using the Indonesian Quality of Life in Epilepsy Inventory-10 (QOLIE-10). Anxiety and depression were measured with the Generalized Anxiety Disorder 7-item (GAD-7) and the Hamilton Depression Rating Scale (HDRS), respectively. Blood samples were used to measure cortisol and brain-derived neurotrophic factor (BDNF) levels. Path analysis was conducted in Stata 13.0 for Windows to model the hypothesized direct and indirect relationships among variables. Model fit was evaluated using Akaike Information Criterion (AIC), Bayesian Information Criterion (BIC), and absolute fit indices. Results: Path analysis revealed a significant negative direct association between BDNF levels and QOLIE-10 scores (B = −0.072, p = 0.017), indicating that higher BDNF levels are associated with improved quality of life, as reflected in lower distress scores. Conversely, seizure frequency (B = 0.23, p = 0.039) and GAD-7 scores (B = 0.70, p < 0.001) were positively associated with QOLIE-10, indicating that increased seizures and anxiety are linked to poorer quality of life. Indirect effects were also identified, with seizure frequency positively influencing both GAD-7 (B = 0.56, p < 0.001) and HDRS scores (B = 0.39, p = 0.002), which, in turn, are significant contributors to a reduced quality of life. The model demonstrated a good fit, with an AIC of 1,272.185 and a BIC of 1,315.064. Conclusions: Managing seizures is not only critical for reducing the direct burden of epilepsy but also essential for mitigating anxiety and depression, which are significant contributors to a reduced quality of life. Our findings underscore the importance of a holistic care approach that addresses seizure control and psychological well-being.
- Open Access
- 1 September 2025
- Published by Garval Editorial Ltda.
- Vol. 13 (5) , 1557-1571
Bibliometric mapping of secretomes, exosomes, and extracellular vesicles in Alzheimer’s disease
Context: Alzheimer’s Disease (AD) is a neurodegenerative disorder with limited treatment options, primarily addressing symptoms without targeting underlying mechanisms. Emerging therapies involving secretomes, exosomes, and extracellular vesicles (EVs) show promise in modulating AD pathology, including amyloid-beta accumulation, tau aggregation, and neuroinflammation. Aims: To conduct a bibliometric analysis of global research on secretomes, exosomes, and EVs in AD to identify trends, key contributors, and future research directions. Methods: A bibliometric analysis was conducted using the Scopus database. A total of 988 studies were identified based on English-language and final publication-stage studies, reviews, and conference papers. The data were analyzed using Scopus tools, the bibliometrics R package (Biblioshiny), and VOSviewer to evaluate publication trends, key contributors, and keyword co-occurrence networks. Results: Research on secretomes, exosomes, and EVs in AD has grown steadily from 2003 to 2025, with a significant increase in publications since 2010. The studies span 397 sources, with an annual growth rate of 6.5% and a high average citation rate per article (65.55). Key topics included fundamental mechanisms (e.g., neuroinflammation, amyloid-beta, tauopathy), biomarker development, and therapeutic approaches. Emerging areas requiring further exploration include clinical applications (e.g., delivery systems), novel biomarkers (e.g., gut–brain axis indicators), and advanced analytical methods (e.g., machine learning, bioinformatics). Conclusions: This study reveals an expanding global interest in the role of secretomes, exosomes, and EVs in AD. It identifies significant trends and research gaps, emphasizing the need for translational efforts that bridge experimental insights and clinical applications. Future efforts should focus on translating promising findings into clinical applications while addressing underexplored topics and fostering international collaboration.
- 1 September 2025
- Published by Garval Editorial Ltda.
- Vol. 13 (5) , 1557-1571
Open AccessBibliometric mapping of secretomes, exosomes, and extracellular vesicles in Alzheimer’s disease
Context: Alzheimer’s Disease (AD) is a neurodegenerative disorder with limited treatment options, primarily addressing symptoms without targeting underlying mechanisms. Emerging therapies involving secretomes, exosomes, and extracellular vesicles (EVs) show promise in modulating AD pathology, including amyloid-beta accumulation, tau aggregation, and neuroinflammation. Aims: To conduct a bibliometric analysis of global research on secretomes, exosomes, and EVs in AD to identify trends, key contributors, and future research directions. Methods: A bibliometric analysis was conducted using the Scopus database. A total of 988 studies were identified based on English-language and final publication-stage studies, reviews, and conference papers. The data were analyzed using Scopus tools, the bibliometrics R package (Biblioshiny), and VOSviewer to evaluate publication trends, key contributors, and keyword co-occurrence networks. Results: Research on secretomes, exosomes, and EVs in AD has grown steadily from 2003 to 2025, with a significant increase in publications since 2010. The studies span 397 sources, with an annual growth rate of 6.5% and a high average citation rate per article (65.55). Key topics included fundamental mechanisms (e.g., neuroinflammation, amyloid-beta, tauopathy), biomarker development, and therapeutic approaches. Emerging areas requiring further exploration include clinical applications (e.g., delivery systems), novel biomarkers (e.g., gut–brain axis indicators), and advanced analytical methods (e.g., machine learning, bioinformatics). Conclusions: This study reveals an expanding global interest in the role of secretomes, exosomes, and EVs in AD. It identifies significant trends and research gaps, emphasizing the need for translational efforts that bridge experimental insights and clinical applications. Future efforts should focus on translating promising findings into clinical applications while addressing underexplored topics and fostering international collaboration.
- Open Access
- 7 March 2025
- Published by Wiley in Epilepsia Open
- Vol. 10 (2) , 571-580
Bromodomain‐containing protein 2 gene polymorphism among patients with photosensitive epilepsy in Indonesia
Objectives: Genetic‐associated epilepsy in the Indonesian population is rarely discussed, and no study was specifically studied about photosensitive epilepsy. The fundamental goal of this research endeavor was to evaluate whether the single nucleotide polymorphism (SNP) of the Bromodomain‐Containing Protein 2 (BRD2) gene gives vulnerability to photosensitive epilepsy among Indonesian descent.Methods: This observational case–control study includes patients of Indonesian descent with Javanese ancestry. Clinical and neurophysiological data, along with electroencephalographic (EEG) recordings, were used to diagnose epilepsy and photosensitive epilepsy. Blood samples were collected and analyzed for BRD2 gene SNPs (rs206781, rs188245, and rs15912) using polymerase chain reaction (PCR), electrophoresis, and the Sanger sequencing method.Results: This study included 27 participants, consisting of 17 patients in the epilepsy group (nine patients with photosensitive epilepsy and eight patients without photosensitive epilepsy) and 10 patients in the non‐epilepsy group. Significant statistical differences were found in genotype (rs206781, p = 0.008 and rs188245, p = 0.004) and allele frequencies (rs206781, p < 0.001 and rs188245, p < 0.001) of the BRD2 gene in Indonesian descent with Javanese race patients diagnosed with photosensitive epilepsy and in those without this condition.Significance: Our study corroborates the observation that genetic diversity within the BRD2 locus (rs206781 and rs188245) is associated with PE in Indonesian descendants of the Javanese race. To acquire a complete knowledge of the development of photosensitive epilepsy, further polymorphism studies at other SNP locations or genes are necessary.Plain Language Summary: This study investigated whether genetic differences in the BRD2 gene were linked to photosensitive epilepsy (a type of epilepsy triggered by visual stimuli like flashing lights) in individuals of Indonesian Javanese descent. We analyzed deoxyribonucleic acid (DNA) samples from patients with epilepsy, including those with photosensitive epilepsy, and found that certain variations in the BRD2 gene were significantly more common in people with photosensitive epilepsy. These findings imply that genetic factors, specifically variations in the BRD2 gene, could elevate the risk of individuals in this population experiencing photosensitive epilepsy.
- 7 March 2025
- Published by Wiley in Epilepsia Open
- Vol. 10 (2) , 571-580
Open AccessBromodomain‐containing protein 2 gene polymorphism among patients with photosensitive epilepsy in Indonesia
Objectives: Genetic‐associated epilepsy in the Indonesian population is rarely discussed, and no study was specifically studied about photosensitive epilepsy. The fundamental goal of this research endeavor was to evaluate whether the single nucleotide polymorphism (SNP) of the Bromodomain‐Containing Protein 2 (BRD2) gene gives vulnerability to photosensitive epilepsy among Indonesian descent.Methods: This observational case–control study includes patients of Indonesian descent with Javanese ancestry. Clinical and neurophysiological data, along with electroencephalographic (EEG) recordings, were used to diagnose epilepsy and photosensitive epilepsy. Blood samples were collected and analyzed for BRD2 gene SNPs (rs206781, rs188245, and rs15912) using polymerase chain reaction (PCR), electrophoresis, and the Sanger sequencing method.Results: This study included 27 participants, consisting of 17 patients in the epilepsy group (nine patients with photosensitive epilepsy and eight patients without photosensitive epilepsy) and 10 patients in the non‐epilepsy group. Significant statistical differences were found in genotype (rs206781, p = 0.008 and rs188245, p = 0.004) and allele frequencies (rs206781, p < 0.001 and rs188245, p < 0.001) of the BRD2 gene in Indonesian descent with Javanese race patients diagnosed with photosensitive epilepsy and in those without this condition.Significance: Our study corroborates the observation that genetic diversity within the BRD2 locus (rs206781 and rs188245) is associated with PE in Indonesian descendants of the Javanese race. To acquire a complete knowledge of the development of photosensitive epilepsy, further polymorphism studies at other SNP locations or genes are necessary.Plain Language Summary: This study investigated whether genetic differences in the BRD2 gene were linked to photosensitive epilepsy (a type of epilepsy triggered by visual stimuli like flashing lights) in individuals of Indonesian Javanese descent. We analyzed deoxyribonucleic acid (DNA) samples from patients with epilepsy, including those with photosensitive epilepsy, and found that certain variations in the BRD2 gene were significantly more common in people with photosensitive epilepsy. These findings imply that genetic factors, specifically variations in the BRD2 gene, could elevate the risk of individuals in this population experiencing photosensitive epilepsy.
- Open Access
- 1 December 2024
- Published by Garval Editorial Ltda. in Journal of Pharmacy & Pharmacognosy Research
- Vol. 12 (s1) , S23-S26
Correlation between lipid profile and cognitive function deterioration in ischemic stroke patients
Context: The second most common type of dementia is vascular dementia, caused by cerebrovascular disease. The decline in cognitive function after ischemic stroke occurs with varying degrees of severity and onset. This variability is attributed to the overlapping neurodegenerative and vascular damage. Aims: To investigate the correlation between lipid profile, a biomarker of vascular dysfunction, and cognitive function in ischemic stroke patients. Methods: A total of 52 respondents (mean age 64.21 ± 9.78 years) were recruited, and the Spearman correlation test found a moderate positive correlation (r=0.658, p=0.04) between lipid profile and cognitive function deterioration. The ordinal regression analysis was used to calculate the odds ratio (OR). Results: The results showed that the OR for cognitive function deterioration associated with high-density lipoprotein (HDL), low-density lipoprotein (LDL), triglycerides, and total cholesterol were -1.54 (95% CI -0.98 - -3.46, p=0.002), 1.78 (95% CI 1.27-2.46, p=0.000), 2.48 (95% CI 1.39-4.92, p=0.04), and 1.54 (95% CI 1.04-2.48, p=0.003) respectively. Conclusion: Based on the results, a positive correlation with moderate strength was observed between lipid profile and cognitive function deterioration in ischemic stroke patients.
- 1 December 2024
- Published by Garval Editorial Ltda. in Journal of Pharmacy & Pharmacognosy Research
- Vol. 12 (s1) , S23-S26
Open AccessCorrelation between lipid profile and cognitive function deterioration in ischemic stroke patients
Context: The second most common type of dementia is vascular dementia, caused by cerebrovascular disease. The decline in cognitive function after ischemic stroke occurs with varying degrees of severity and onset. This variability is attributed to the overlapping neurodegenerative and vascular damage. Aims: To investigate the correlation between lipid profile, a biomarker of vascular dysfunction, and cognitive function in ischemic stroke patients. Methods: A total of 52 respondents (mean age 64.21 ± 9.78 years) were recruited, and the Spearman correlation test found a moderate positive correlation (r=0.658, p=0.04) between lipid profile and cognitive function deterioration. The ordinal regression analysis was used to calculate the odds ratio (OR). Results: The results showed that the OR for cognitive function deterioration associated with high-density lipoprotein (HDL), low-density lipoprotein (LDL), triglycerides, and total cholesterol were -1.54 (95% CI -0.98 - -3.46, p=0.002), 1.78 (95% CI 1.27-2.46, p=0.000), 2.48 (95% CI 1.39-4.92, p=0.04), and 1.54 (95% CI 1.04-2.48, p=0.003) respectively. Conclusion: Based on the results, a positive correlation with moderate strength was observed between lipid profile and cognitive function deterioration in ischemic stroke patients.
- Open Access
- 14 November 2024
- Published by International Association of Online Engineering (IAOE) in International Journal of Online and Biomedical Engineering (iJOE)
- Vol. 20 (14) , 139-159
AI-Enhanced Biosignal Analysis for Obstructive Sleep Apnea Detection: A Comprehensive Review
Obstructive sleep apnea (OSA) detection using single-lead electrocardiograms (ECGs) has advanced significantly with the integration of artificial intelligence (AI). This review explores how AI enhances feature extraction and machine learning algorithms to improve OSA detection. The RR interval in electrocardiographic data is particularly valued for its ease of identification and low error rate. We review a range of machine learning and deep learning techniques employed in OSA detection. This review offers insights into developing single-lead ECG-based OSA detection systems by analyzing database availability, feature extraction methods, and machine learning approaches.
- 14 November 2024
- Published by International Association of Online Engineering (IAOE) in International Journal of Online and Biomedical Engineering (iJOE)
- Vol. 20 (14) , 139-159
Open AccessAI-Enhanced Biosignal Analysis for Obstructive Sleep Apnea Detection: A Comprehensive Review
Obstructive sleep apnea (OSA) detection using single-lead electrocardiograms (ECGs) has advanced significantly with the integration of artificial intelligence (AI). This review explores how AI enhances feature extraction and machine learning algorithms to improve OSA detection. The RR interval in electrocardiographic data is particularly valued for its ease of identification and low error rate. We review a range of machine learning and deep learning techniques employed in OSA detection. This review offers insights into developing single-lead ECG-based OSA detection systems by analyzing database availability, feature extraction methods, and machine learning approaches.
- Open Access
- 1 September 2024
- Published by Institute of Advanced Engineering and Science in International Journal of Public Health Science (IJPHS)
- Vol. 13 (3) , 1317-1324
Correlation of electrolytes with falling risk, cognitive function, and functional outcome in acute ischemic stroke patient
Stroke outcome is determined on multiple factors. However, there are limited studies discussing the impact of electrolyte imbalance on stroke outcome. In this study, we analyzed sodium, calcium, and potassium level in acute ischemic stroke, and compare their risk of falling, cognitive function, and functional outcome. This was a cross-sectional study in Dr. Moewardi General Hospital, Indonesia between January and June 2023. Patient with acute ischemic stroke were enrolled in this study. Cognitive function was assessed with mini mental state examination (MMSE) and the Indonesian version of montreal cognitive assessment (MoCA-Ina). National Institutes of Health Stroke Scale (NIHSS), Modified Rankin Scale (MRS) and Morse Fall Score (MFS) were used to assessed stroke severity, disability, and risk of falling, respectively. Pearson correlation was then performed to evaluate the correlation of electrolytes level with MMSE, MoCA-Ina, NIHSS, MRS, and MFS. Furthermore, we also analyzed the odds ratio of increasing risk of falling, cognitive function deterioration, and worse functional outcome. A p-value of <0.05 is considered statistically significant. On univariate analysis, natrium is correlated with MMSE (r=0.174; p=0.042), NIHSS (r=-0.412; p=0.011), MRS (r=-0.174; p=0.042), and MFS (r=-0.304; p=0.042). Potassium is correlated with MMSE (r=0.344; p=0.044), MoCA-INA (r=0.341; p=0.048), NIHSS (r=-0.572; p=0.019), (MRS r=-0.376; p=0.017), and MFS (r=-0.612; p=0.031). Calcium is correlated with NIHSS r=-0.348 (p=0.018), MRS r=-0.256 (p=0.036). On odds ratio analysis, low natrium level increased the risk of deteriorating cognitive function, and low level of potassium increased the risk of falling. Electrolyte imbalances correlates with risk of falling and deteriorating cognitive function.
- 1 September 2024
- Published by Institute of Advanced Engineering and Science in International Journal of Public Health Science (IJPHS)
- Vol. 13 (3) , 1317-1324
Open AccessCorrelation of electrolytes with falling risk, cognitive function, and functional outcome in acute ischemic stroke patient
Stroke outcome is determined on multiple factors. However, there are limited studies discussing the impact of electrolyte imbalance on stroke outcome. In this study, we analyzed sodium, calcium, and potassium level in acute ischemic stroke, and compare their risk of falling, cognitive function, and functional outcome. This was a cross-sectional study in Dr. Moewardi General Hospital, Indonesia between January and June 2023. Patient with acute ischemic stroke were enrolled in this study. Cognitive function was assessed with mini mental state examination (MMSE) and the Indonesian version of montreal cognitive assessment (MoCA-Ina). National Institutes of Health Stroke Scale (NIHSS), Modified Rankin Scale (MRS) and Morse Fall Score (MFS) were used to assessed stroke severity, disability, and risk of falling, respectively. Pearson correlation was then performed to evaluate the correlation of electrolytes level with MMSE, MoCA-Ina, NIHSS, MRS, and MFS. Furthermore, we also analyzed the odds ratio of increasing risk of falling, cognitive function deterioration, and worse functional outcome. A p-value of <0.05 is considered statistically significant. On univariate analysis, natrium is correlated with MMSE (r=0.174; p=0.042), NIHSS (r=-0.412; p=0.011), MRS (r=-0.174; p=0.042), and MFS (r=-0.304; p=0.042). Potassium is correlated with MMSE (r=0.344; p=0.044), MoCA-INA (r=0.341; p=0.048), NIHSS (r=-0.572; p=0.019), (MRS r=-0.376; p=0.017), and MFS (r=-0.612; p=0.031). Calcium is correlated with NIHSS r=-0.348 (p=0.018), MRS r=-0.256 (p=0.036). On odds ratio analysis, low natrium level increased the risk of deteriorating cognitive function, and low level of potassium increased the risk of falling. Electrolyte imbalances correlates with risk of falling and deteriorating cognitive function.
- Open Access
- 5 June 2024
- Published by MDPI AG in Preprints.org
A Systematic Review of Secretome-Based Therapies for Alzheimer's Disease: Bridging the Preclinical and Clinical Gap
Background: Alzheimer's Disease (AD) is a progressive neurodegenerative disorder with a rapidly increasing prevalence. Current therapeutic options primarily manage symptoms, not modifying the disease. Secretome-based therapies have emerged as a promising avenue for AD treatment in targeting multiple pathways and promoting neuroprotection and regeneration. This systematic review evaluated the preclinical and clinical evidences for secretome-based therapies in AD.Methods: A systematic search was conducted across Scopus, PubMed, ScienceDirect, and Cochrane Library. The SYRCLE risk of bias (RoB) tool was used for preclinical studies and Cochrane RoB 2.0 for clinical studies. We performed qualitative analysis of study results.Results: Included 21 in vivo studies and 2 clinical trials revealed promising outcomes of treatments involving secretomes, exosomes, and extracellular vesicles from different cell sources. The therapies could reduce amyloid plaque load, reactive gliosis, and enhance neuronal density. These findings suggested the treatments reveal mechanism of action in neuroprotection, neuroregeneration, and inflammation modulation, which are critical in AD pathology. Ongoing trials also supported the safety and efficacy of the treatment strategies. However, translational medical study faces several challenges regarding large-scale production, optimization of protocols, and understanding biomarkers. The heterogeneity in secretome-based therapies administration have complicated the comparison of study outcomes and the translation of preclinical findings into clinical settings. Deeper understanding of the secretome's mechanisms of action, optimal dosing, and delivery methods are needed to maximize therapeutic outcomes.Conclusion: Despite secretome-based therapies hold significant promise for AD treatment, addressing the identified gaps and limitations is crucial for advancing these therapies from preclinical research to clinical practice.
- 5 June 2024
- Published by MDPI AG in Preprints.org
Open AccessA Systematic Review of Secretome-Based Therapies for Alzheimer's Disease: Bridging the Preclinical and Clinical Gap
Background: Alzheimer's Disease (AD) is a progressive neurodegenerative disorder with a rapidly increasing prevalence. Current therapeutic options primarily manage symptoms, not modifying the disease. Secretome-based therapies have emerged as a promising avenue for AD treatment in targeting multiple pathways and promoting neuroprotection and regeneration. This systematic review evaluated the preclinical and clinical evidences for secretome-based therapies in AD.Methods: A systematic search was conducted across Scopus, PubMed, ScienceDirect, and Cochrane Library. The SYRCLE risk of bias (RoB) tool was used for preclinical studies and Cochrane RoB 2.0 for clinical studies. We performed qualitative analysis of study results.Results: Included 21 in vivo studies and 2 clinical trials revealed promising outcomes of treatments involving secretomes, exosomes, and extracellular vesicles from different cell sources. The therapies could reduce amyloid plaque load, reactive gliosis, and enhance neuronal density. These findings suggested the treatments reveal mechanism of action in neuroprotection, neuroregeneration, and inflammation modulation, which are critical in AD pathology. Ongoing trials also supported the safety and efficacy of the treatment strategies. However, translational medical study faces several challenges regarding large-scale production, optimization of protocols, and understanding biomarkers. The heterogeneity in secretome-based therapies administration have complicated the comparison of study outcomes and the translation of preclinical findings into clinical settings. Deeper understanding of the secretome's mechanisms of action, optimal dosing, and delivery methods are needed to maximize therapeutic outcomes.Conclusion: Despite secretome-based therapies hold significant promise for AD treatment, addressing the identified gaps and limitations is crucial for advancing these therapies from preclinical research to clinical practice.
- Open Access
- 30 January 2024
- Published by Universa Medicina in Universa Medicina
- Vol. 43 (1) , 61-68
The effect of listening to Holy Quran recitation on stress among healthy adults: a non-blinded randomized controlled trial
Universa Medicina is a four-monthly medical journal that publishes new research findings on a wide variety of topics of importance to biomedical science and clinical practice
- 30 January 2024
- Published by Universa Medicina in Universa Medicina
- Vol. 43 (1) , 61-68
Open AccessThe effect of listening to Holy Quran recitation on stress among healthy adults: a non-blinded randomized controlled trial
Universa Medicina is a four-monthly medical journal that publishes new research findings on a wide variety of topics of importance to biomedical science and clinical practice